SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis

Neurobiology of Disease

Volumn 39, Issue 2, 2010, Pages 198-203

  Gagliardi, Stella ^a,b   Cova, Emanuela ^a   Davin, Annalisa ^a   Guareschi, Stefania ^a,b   Abel, Kenneth ^c   Alvisi, Elena ^a,b   Laforenza, Umberto ^b   Ghidoni, Roberta ^d   Cashman, John Richard ^c   Ceroni, Mauro ^a,b   Cereda, Cristina ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c HUMAN BIOMOLECULAR RESEARCH INSTITUTE   (United States)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Brain stem; Cerebellum; Fibroblasts; Lymphocytes; MRNA; Non motor cerebral cortex; SOD1; Spinal cord

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA;

ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; BRAIN STEM; CELL LEVEL; CELL SPECIFICITY; CELL STRESS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TISSUE LEVEL;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; BRAIN; CASE-CONTROL STUDIES; FEMALE; FIBROBLASTS; GENETIC TESTING; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NERVOUS SYSTEM; RNA, MESSENGER; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 77953696899     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.04.008     Document Type: Article

References (32)

1. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 2004, 10. Suppl., S18-25.
2. Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000, 1:293-299.
3. Broom W.J., Greenway M., Sadri-Vakili G., Russ C., Auwarter K.E., Glajch K.E., Dupre N., Swingler R.J., Purcell S., Hayward C., Sapp P.C., McKenna-Yasek D., Valdmanis P.N., Bouchard J.P., Meininger V., Hosler B.A., Glass J.D., Polack M., Rouleau G.A., Cha J.H., Hardiman O., Brown R.H. 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2008, 9:229-237.
4. Cedarbaum J.M., Stambler N. Performance of the amyotrophic lateral sclerosis functional rating scale (ALSFRS) in multicenter clinical trials. J. Neurol. Sci. 1997, 152(Suppl 1):S1-S9.
5. Chou S.M., Han C.Y., Wang H.S., Vlassara H., Bucala R. A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study. J. Neurol. Sci. 1999, 169:87-92.
6. Cova E., Cereda C., Galli A., Curti D., Finotti C., Di Poto C., Corato M., Mazzini G., Ceroni M. Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci. Lett. 2006, 399:186-190.
7. Ezzi S.A., Urushitani M., Julien J.P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007, 102:170-178.
8. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 2008, 63:535-538.
9. Gruzman A., Wood W.L., Alpert E., Prasad M.D., Miller R.G., Rothstein J.D., Bowser R., Hamilton R., Wood T.D., Cleveland D.W., Lingappa V.R., Liu J. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(30):12524-12529.
10. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
11. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57:236-251.
12. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
13. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
14. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991, 19:5444.
15. Laforenza U., Gastaldi G., Polimeri M., Tritto S., Tosco M., Ventura U., Scaffino M.F., Yasui M. Aquaporin-6 is expressed along the rat gastrointestinal tract and upregulated by feeding in the small intestine. BMC Physiol. 2009, 7:9-18.
16. Lederer C.W., Torrisi A., Pantelidou M., Santama N., Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 2007, 8:26.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(t)) method. Methods 2001, 25:402-408.
18. Luquin N., Yu B., Trent R.J., Morahan J.M., Pamphlett R. An analysis of the entire SOD1 gene in sporadic ALS. Neuromuscul. Disord. 2008, 18:545-552.
19. Matsumoto S., Kusaka H., Ito H., Shibata N., Asayama T., Imai T. Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive Lewy body-like inclusions. Clin. Neuropathol. 1996, 15:41-46.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department Of Health And Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
21. Niemann S., Broom W.J., Brown R.H. Analysis of a genetic defect in the TATA box of the SOD1 gene in a patient with familial amyotrophic lateral sclerosis. Muscle Nerve 2007, 36:704-707.
22. Puttaparthi K., Gitomer W.L., Krishnan U., Son M., Rajendran B., Elliott J.L. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J. Neurosci. 2002, 22:8790-8796.
23. Rakhit R., Crow J.P., Lepock J.R., Kondejewski L.H., Cashman N.R., Chakrabartty A. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 2004, 279:15499-15504.
24. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella G.S., Horvitz H.R., Brown R.H.J. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364:362.
25. Sala G., Trombin F., Mattavelli L., Beretta S., Tremolizzo L., Andreoni S., Calabrese E., Sanvito L., Ferrarese C. Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts. Neurodegener Dis. 2009, 6:9-15.
26. Shibata N., Hirano A., Kobayashi M., Sasaki S., Kato T., Matsumoto S., Shiozawa Z., Komori T., Ikemoto A., Umahara T., Asayama K. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 1994, 179:149-152.
27. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
28. Strong M.J. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J. Neurol. Sci. 2009, 288:1-12.
29. Tatone C., Carbone M.C., Falone S., Aimola P., Giardinelli A., Caserta D., Marci R., Pandolfi A., Ragnelli A.M., Amicarelli F. Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Mol. Hum. Reprod. 2006, 12(11):655-660.
30. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
31. Wang X.S., Simmons Z., Liu W., Boyer P.J., Connor J.R. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph. Lateral Scler. 2006, 7:201-210.
32. Xu Y., Wu T., Jin Y., Fu Z. Effects of age and jet lag on d-galactose induced aging process. Biogerontology 2009, 10:153-161.